Clinical Trials | June 02, 2026
BioNTech and Bristol Myers Squibb drug shows strong early signal in lung cancer trial
The safety profile was described as manageable, though not without notable toxicities
The safety profile was described as manageable, though not without notable toxicities
The trial results are for the pharma powerhouse's RET-targeted therapy Retevmo (selpercatinib)
Fertility platform launches flagship clinic with advanced IVF tech
Increasing syphilis cases, stronger STI surveillance initiatives, and growing emphasis on early diagnosis are expected to support sustained demand
Initiatives at Churchgate Station and Mahindra & Mahindra focus on early detection, public education, and tobacco-related cancer prevention
While oncology contributed Rs. 16,100.9 million to remain company's largest therapy area, the key highlight was receipt of 11 new regulatory approvals for medicines and indications
Seasoned HR leader brings over 15 years of experience in global talent strategy, organizational transformation, and workforce planning
Vijay brings more than 28 years of experience across healthcare, technology, edtech, manufacturing, and global business environments
World MS Day 2026 conclave brings together MPs, neurologists, disability rights advocates and insurance stakeholders to push for reforms in healthcare access, disability recognition and social protection
We have the chance to build an IP estate that goes hand in hand with our generic pharmaceutical strength and build proprietary biological platforms
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
